A cloud-based platform for analyzing cancer data from blood samples.
NCI SBIR Contract Topic 428 Phase II (Solicitation Number: BAA 75N91022R00027): Cloud-based Liquid-biopsy and Radiomics Platform for the Cancer Research Data Commons
['FUNDING_OTHER'] · EARLYDIAGNOSTICS, INC. · NIH-10906504
This study is creating a user-friendly online platform that combines blood test results with a lot of cancer research information to help find and treat cancer better, and patients can help by sharing their blood samples for this important work.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | EARLYDIAGNOSTICS, INC. (nih funded) |
| Locations | 1 site (LOS ANGELES, UNITED STATES) |
| Trial ID | NIH-10906504 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a cloud-computing platform that integrates liquid biopsy data with extensive cancer research datasets. By analyzing genomic and epigenomic profiles from blood samples, the platform aims to enhance cancer detection and treatment strategies. The project will finalize a prototype that combines multi-omics and imaging data, utilizing advanced deep learning tools for comprehensive analysis. Patients can contribute their blood samples, which will be analyzed alongside large datasets to improve personalized cancer care.
Who could benefit from this research
Good fit: Ideal candidates include individuals undergoing cancer treatment or those at high risk for developing cancer who are willing to provide blood samples.
Not a fit: Patients with non-cancerous conditions or those who are not willing to participate in blood sample collection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and non-invasive methods for cancer detection and treatment.
How similar studies have performed: Previous research has shown promising results in using liquid biopsies and multi-omics analysis for cancer detection, indicating a strong potential for success in this approach.
Where this research is happening
LOS ANGELES, UNITED STATES
- EARLYDIAGNOSTICS, INC. — LOS ANGELES, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LIU, CHUN-CHI (JIM) — EARLYDIAGNOSTICS, INC.
- Study coordinator: LIU, CHUN-CHI (JIM)
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.